Low-dose xenogeneic mesenchymal stem cells target canine osteoarthritis through systemic immunomodulation and homing.
Beerts C, Broeckx SY, Depuydt E, Tack L, Van Hecke L, Chiers K, Van Brantegem L, Braun G, Hellmann K, de Bouvre N, Van Bruaene N, De Ryck T, Duchateau L, Van Ryssen B, Peremans K, Saunders JH, Verhoeven G, Pauwelyn G, Spaas JH.
Beerts C, et al. Among authors: peremans k.
Arthritis Res Ther. 2023 Oct 3;25(1):190. doi: 10.1186/s13075-023-03168-7.
Arthritis Res Ther. 2023.
PMID: 37789403
Free PMC article.